Study Shows Abortion Pill Could Prevent Breast Cancer

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


A new study just released, reports the Washington Post, shows mifepristone, the active component of the abortion pill regimen RU-486, may stave off breast cancer. The research shows that BRCA1, a gene that causes breast cancer, actually accelerates the production of progesterone (a necessary hormone for pregnant women) in the body. Mifepristone blocks progesterone, and scientists discovered that it was very effective in shutting down cancer-causing genes in mice. It was actually 100% effective. Proponents of RU-486 are hoping that this new advancement will make the drug more available and therefore pave the way for women to use the pill for abortions. Scientists, though, are not yet convinced (and neither should you be– the long-term effects of RU-486 have not been studied because the drug is meant for one-time use only). There are concerns that long-term use of RU-486 by humans suppresses the immune system and scientists are looking into other progesterone blocking options. So, this is likely not, nor should it be hyped as, the pro-choice ticket to off-label cancer fighting use of RU-486, but, then again, it isn’t bad news for the much maligned abortion pill.

TIME IS RUNNING OUT!

We have an ambitious $350,000 online fundraising goal this month and it's truly crunch time: About 15 percent of our yearly online giving usually comes in during the final week of the year, and in "No Cute Headlines or Manipulative BS," we explain why we simply can't afford to come up short right now.

The bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. And advertising or profit-driven ownership groups will never make time-intensive, in-depth reporting viable.

That's why donations big and small make up 74 percent of our budget this year. There is no backup to keep us going, no alternate revenue source, no secret benefactor. If readers don’t donate, we won’t be here. It's that simple.

And if you can help us out with a donation right now, all online gifts will be matched thanks to an incredibly generous matching gift pledge.

payment methods

TIME IS RUNNING OUT!

We have an ambitious $350,000 online fundraising goal this month and it's truly crunch time: About 15 percent of our yearly online giving usually comes in during the final week of the year, and in "No Cute Headlines or Manipulative BS," we explain why we simply can't afford to come up short right now.

The bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. And advertising or profit-driven ownership groups will never make time-intensive, in-depth reporting viable.

That's why donations big and small make up 74 percent of our budget this year. There is no backup to keep us going, no alternate revenue source, no secret benefactor. If readers don’t donate, we won’t be here. It's that simple.

And if you can help us out with a donation right now, all online gifts will be matched thanks to an incredibly generous matching gift pledge.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate